Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448

Fig. 2

Correlation of KDM5B expression with patients’ survival. Kaplan-Meier curves with univariate analyses (log-rank) of KDM5B expression in triple negative breast cancer patients stratified as high and low KDM5B, where high KDM5B was defined as >80 % average nuclear expression, while low KDM5B <80 % nuclear expression (*P < 0.05). a OS according to nuclear KDM5B immunohistochemical expression in TNBC tissues from the Mackay Memorial Hospital cohort of 270 patients. b OS according to nuclear KDM5B immunohistochemical expression in TNBC tissues from the GEO breast cancer cohort. c DMFS according to nuclear KDM5B immunohistochemical expression in TNBC tissues from the GEO breast cancer cohort. d RFS according to nuclear KDM5B immunohistochemical expression in TNBC tissues from the GEO breast cancer cohort. OS, overall survival; DMFS, distance metastasis-free survival; RFS, relapse-free survival

Back to article page